Kammer Robert J 4
4 · Imprimis Pharmaceuticals, Inc. · Filed Sep 5, 2018
Insider Transaction Report
Form 4
Kammer Robert J
DirectorChairman of the Board10% Owner
Transactions
- Sale
Common Stock
2018-09-04$3.00/sh−10,000$30,000→ 919,827 total
Footnotes (1)
- [F1]This transaction was effected pursuant to a Rule 10b5-1 trading plan, as amended, adopted by the Reporting Person.